Bridgefront Capital »

United Therapeutics Corporation shares owned by Bridgefront Capital

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Bridgefront Capital from 13F filings

Historical chart of Bridgefront Capital investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Bridgefront Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Bridgefront Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 2.7k 419.21
2025-06-30 $946k 3.3k 287.35
2023-12-31 $203k 925 219.89
2022-09-30 $307k 1.5k 209.27

More positions owned by Bridgefront Capital

Lam Research Corp Com New (LRCX)
Honeywell International (HON)
Autodesk (ADSK)
Guidewire Software (GWRE)
Visa Com Cl A (V)
Altria (MO)
Boston Scientific Corporation (BSX)
Tyson Foods Cl A (TSN)
Citigroup Com New (C)
Procter & Gamble Company (PG)
Keurig Dr Pepper (KDP)
International Flavors & Fragrances (IFF)
CRH Ord (CRH)
Nortonlifelock (GEN)
Analog Devices (ADI)

View all positions for Bridgefront Capital

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Assetmark
Invesco
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation